After Cirsiliol intervention, MDA levels were significantly reduced (p < 0.001) compared to the DCM group, and SOD levels were increased (p < 0.01), suggesting that its protective effect in DCM might be through reducing lipid peroxidation, restoring SOD activity, and alleviating oxidative stress damage. The gene discussed is SOD1; the disease is familial dilated cardiomyopathy.